Literature DB >> 19758274

Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study.

A Gramenzi1, F Conti, F Felline, C Cursaro, A Riili, M Salerno, S Gitto, L Micco, A Scuteri, P Andreone, M Bernardi.   

Abstract

Chronic hepatitis C virus (HCV) infection has been poorly investigated in the elderly. The aim of this study was to identify the age-specific characteristics of chronic hepatitis C by comparing patients > or =65 years with those <65 years. A cross-sectional study was performed on data collected from consecutive outpatients referred for the first time to two tertiary outpatient clinics for liver diseases located in Bologna (Northern Italy) and Paola, Cosenza (Southern Italy) over a two-year period. A total of 560 anti-HCV and HCV-RNA positive patients were enrolled, of whom 174 (31%) were 65 years or older. The proportion of older patients was significantly higher in the Southern Italy centre, accounting for more than 40%. Comparison of younger and older groups showed that 51% patients > or =65 years had advanced liver disease (liver cirrhosis or hepatocellular carcinoma) compared with 26% younger patients (P < 0.0001). About half of the patients > or =65 years were not aware of their anti-HCV positive status, even if they tended to be more symptomatic than the younger group. By multivariate analysis, age > or = 65 years, alcohol consumption and diabetes were independently associated with advanced liver disease. Overall, 34 out of 174 patients (20%) > or =65 years had received antiviral treatment compared with 122 out of 386 (32%) younger patients (P = 0.003). Our results further emphasize the notion that chronic hepatitis C is becoming a disease of the elderly and that elderly patients with chronic HCV infection often have severe and underestimated disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19758274     DOI: 10.1111/j.1365-2893.2009.01189.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  6 in total

1.  Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection.

Authors:  Claudia Roeder; Sabine Jordan; Julian Schulze Zur Wiesch; Heike Pfeiffer-Vornkahl; Dietrich Hueppe; Stefan Mauss; Elmar Zehnter; Sabine Stoll; Ulrich Alshuth; Ansgar W Lohse; Stefan Lueth
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 2.  Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens.

Authors:  Umberto Vespasiani-Gentilucci; Giovanni Galati; Paolo Gallo; Antonio De Vincentis; Elisabetta Riva; Antonio Picardi
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

3.  Treatment Response and Tolerability of Pegylated Interferon-α Plus Ribavirin Combination Therapy in elderly Patients (≥ 65 years) With Chronic Hepatitis C in Korea.

Authors:  Hyeong Il Kim; In Hee Kim; Byung Jun Jeon; Seok Lee; Seong Hun Kim; Sang Wook Kim; Seung Ok Lee; Soo Teik Lee; Dae Ghon Kim
Journal:  Hepat Mon       Date:  2012-07-30       Impact factor: 0.660

4.  Determinant Factors of the Direct Medical Costs Associated with Genotype 1 Hepatitis C Infection in Treatment-Experienced Patients.

Authors:  Essè Ifèbi Hervé Akpo; Urbano Sbarigia; George Wan; Joris Kleintjens
Journal:  Drugs R D       Date:  2015-12

5.  Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older.

Authors:  Anca Trifan; Carol Stanciu; Liana Gheorghe; Speranta Iacob; Manuela Curescu; Cristina Cijevschi Prelipcean; Gabriela Stefanescu; Irina Girleanu; Stefan Chiriac; Catalina Mihai; Ciprian Brisc; Adrian Goldis; Ioan Sporea; Egidia Miftode; Simona Bataga; Ion Rogoveanu; Carmen Preda; Florin Alexandru Caruntu; Ana-Maria Singeap
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

6.  Predictors of Inpatient Mortality and Resource Utilization for the Elderly Patients With Chronic Hepatitis C (CH-C) in the United States.

Authors:  Pegah Golabi; Munkhzul Otgonsuren; Winnie Suen; Aaron B Koenig; Bashir Noor; Zobair M Younossi
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.